[Current research results with class III antiarrhythmia agents. Anti-arrhythmia agents with minimal pro-arrhythmia risk?].
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000145:classification* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000517:prevention & control; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers